FDA's regulations do not specifically address methods for shipping the study drug but do require that control of the study drug be maintained. FDA's regulations do address documentation of shipment of the study drug and, for example, would include information such as the lot number or other identification of the product transferred, the dates, the means of shipment, and the sites involved. Both the research pharmacy and satellite site will need to maintain documentation.